skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello, I have the Mackenzie fund mfc244 that has done very well for me over the years and pays me a nice dividend every month. Is the a cdn etf that would be comparable in performance and payout but would have a much lower mer? Thanks
Read Answer Asked by pietro on August 10, 2021
Q: Good Afternoon 5i,
After reading the recent edition of your ETF newsletter, I am inclining to invest a bit directly in China. I already hold VWO but, after reading the well reasoned and written article of yours, I may want a direct, China only etf. Especially now that Chinise stocks have been hammered. Although i am a long term investor, I thought I might capitalise on this fall of Chinese stocks. I think it is most prominent in the technology sector. For that reason I am leaning towards KWEB rather than MCHI. But, when I read the article I see that three of the top ten holdings in both are Tencent, Alibaba and Meitvan, with a similar weighting. Although 63 percent of Kweb and 44 percent of MCHI are the weights for the top ten holdings. That is a difference but it doesn't seem like a lot. So, it looks to me that I get a pretty good cut of the technology stocks in MCHI, as well as more safety. I am therefore leaning in that direction. But, I am tempted by a tech comeback, where I might make a bit more with KWEB. I know it comes down to personal decision. But, I have a bit of trouble understanding how big a difference there would be between the two in a tech comeback. So, I thought I would ask the professionals how you would look at this?
thanks for all your great work
Read Answer Asked by joseph on August 10, 2021
Q: An article in today's TorStar indicated that the company will sell 7.7 million shares at a price of $93per share. The underwriters have been granted an over allotment option up to 1.155 million shares.

It's not clear that the dollars quoted were in U.S. or Cdn dollars. If it's in Cdn. then the Monday closing price of $116.57 is within range. Can you confirm? Thanks.
Read Answer Asked by Victor on August 10, 2021
Q: Hi 5i,

Thanks for the GSY suggestion last year. I am up 400%! That pick will pay for my membership for decades. Thanks to that I am overweight financials. Good problem to have I guess.

As a result, I am underweight industrials and basic materials. I have some cash in my TFSA to deploy. May I have your best idea in those sectors? Thanks in advance.
Read Answer Asked by Dan on August 10, 2021
Q: Hi 5i,
Can you clarify the logic in having a portion of the portfolio in cash? I have seen in past questions you reference a lean stance on cash still being around 7%.
Read Answer Asked by Kyle on August 10, 2021
Q: Hi Team,

Can you comment on the quarter?

Thanks!
Read Answer Asked by David on August 10, 2021
Q: Hello:

Could you explain the difference between TSU and BAMR? Could you also explain the Reinsurance industry? With TSU doing very well recently and the BAMR spinout, it seems like a developing field ie good growth investment potential. Which of the two would you pick from a more conservative, balanced perspective?

My thanks.
Read Answer Asked by David C. on August 10, 2021
Q: The data currently coming from Israel and the UK indicate that the vaccine efficacy is waning, earlier than many predicted. Given that most Western countries have employed a vaccine strategy to address Covid, I would like your advice regarding how to position a portfolio in the event of a Black Swan event.

In the fall, we will likely have another flu/virus season in northern US and Canada. Basically, I see 4 possible scenarios of decreasing probability but increasing risk: (1) the vaccine acts as advertised and we have few cases/deaths; (2) the vaccine is less effective than expected and there are many cases, but few deaths; (3) the vaccine is not effective and there are both many cases and many deaths; and (4) as has been suggested by some top scientists, there are long-term risks with these mRNA vaccines and deaths/ adverse events are much greater than if no vaccine was taken.

If an investor has concerns about scenarios 3 and 4 in particular, but is hopeful that such an event does not occur, how should one best position the portfolio. Should one stay fully diversified sectorially and geographically in stocks? Should one consider increasing allocations to gold, cash, bonds, etc? What are your thoughts?

Many thanks for your insightful advice.
Read Answer Asked by Dale on August 10, 2021
Q: Dear 5i,

If one were to use these two ratios; P/E and P/OpCashFlow to get a rough idea of valuation. Based on historical ratios. As a rough guide how many years averages would you recommend. I think 1 Year is too short. I was thinking perhaps at least 3 to 5 year averages. Where could one find this data and where could I find the corresponding Earnings Growth and Operating Cash Flow growth figure?

thanks
Read Answer Asked by Ian on August 10, 2021
Q: Are there any sites you would recommend where you can see which companies are buying back shares? Or what is the best avenue to obtain this information for multiple stocks? Thanks, Marc
Read Answer Asked by Marc on August 10, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!